More on WAT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $418.64 |
|
|||
| Open | $424.00 | ||||
| 52 Wk High | $162.53 | ||||
| 52 Wk Low | $112.00 | ||||
| Day High | $431.78 | ||||
| Day Low | $422.06 | ||||
| P/E | 82.64 | ||||
| EPS | $5.20 | ||||
| Volume | 688,576 | ||||
- Waters launches BD FACSDiscover A7 Cell Analyzer globally
- Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
- Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
- UBS Assumes Waters Corp. (WAT) at Buy
- Waters Corp. (WAT) PT Raised to $456 at Baird
- Waters Corp. (WAT) PT Raised to $455 at HSBC
- Form 3 WATERS CORP /DE/ For: Aug 21 Filed by: Wu Tong (NMN)
- Morgan Stanley sees Waters best positioned after China lab pricing rules
- Piper Sandler Upgrades Waters Corp. (WAT) to Overweight
- Waters Corporation to Present at the Wells Fargo Healthcare Conference
Entities mentioned with WAT
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- Show More...
